Jochen Wöhrle

Showing 1-9 of 9 articles

Interventions for valvular disease

Matched comparison of next- and early-generation balloon-expandable transcatheter heart valve implantations in failed surgical aortic bioprostheses

Seiffert M, Treede H, Schofer J, Linke A, Wöhrle J, Baumbach H, Mehilli J, Bapat V, Simonato M, Walther T, Kullmer M, Boekstegers P, Ensminger S, Kurz T, Eltchaninoff H, Rastan A, Werner N, de Weger A, Frerker C, Lauer B, Mueller O, Whisenant B, Thukkani A, Weisz G, Dvir D

July 20, 2018 | 10.4244/EIJ-D-17-00546

Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)

Nef H, Wiebe J, Kastner J, Mehilli J, Münzel T, Naber C, Neumann T, Richardt G, Schmermund A, Wöhrle J, Zahn R, Riemer T, Achenbach S, Hamm C

December 20, 2017 | 10.4244/EIJ-D-17-00330

Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R

Mehilli J, Achenbach S, Wöhrle J, Baquet M, Riemer T, Münzel T, Nef H, Naber C, Richardt G, Zahn R, Gori T, Neumann T, Kastner J, Schmermund A, Hamm C, Wöhrle J, Richardt G

December 20, 2017 | 10.4244/EIJ-D-17-00291

Coronary interventions

Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial

Fajadet J, Neumann F, Hildick-Smith D, Petronio A, Zaman A, Spence M, Wöhrle J, Elhadad S, Roberts D, Hovasse T, Valdes M, Silber S

January 20, 2017 | 10.4244/EIJV12I13A262

Interventions for valvular disease

Transfemoral aortic valve implantation with the repositionable Lotus valve for treatment of patients with symptomatic severe aortic stenosis: results from a single-centre experience

Wöhrle J, Gonska B, Rodewald C, Seeger J, Scharnbeck D, Rottbauer W

August 20, 2016 | 10.4244/EIJV12I6A124

Coronary interventions

Bioresorbable polymer sirolimus-eluting coronary stent compared with permanent polymer everolimus-eluting coronary stent implantation for treatment of small vessel coronary artery disease: CENTURY II trial

Wöhrle J, Markovic S, Rottbauer W, Muramatsu T, Kadota K, Vázquez-González N, Odenstedt J, Serra A, Antoniucci D, Varenne O, Saito S, Wijns W

June 10, 2016 | 10.4244/EIJV12I2A30

Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds

Wöhrle J, Naber C, Schmitz T, Schwenke C, Frey N, Butter C, Brachmann J, Ingwersen M, Drabik A, Markovic S, Mathey D

June 19, 2015 | 10.4244/EIJY14M12_10

Efficacy of different devices for transcatheter closure of patent foramen ovale assessed by serial transoesophageal echocardiography and rates of recurrent cerebrovascular events in a long-term follow-up

Luani B, Markovic S, Krumsdorf U, Rottbauer W, Wöhrle J

May 19, 2015 | 10.4244/EIJY15M01_02

Intracoronary application of abciximab in patients with ST-elevation myocardial infarction

Wöhrle J, Nusser T, Mayer C, Kochs M, Hombach V

January 20, 2008

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

October 19, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.

Transcatheter Paravalvular Leak Closure: Catch Me If You Can

Thomas Pilgrim et al.

October 20, 2021

STATE OF THE ART

Glucose-Lowering Therapy in Patients undergoing Percutaneous Coronary Intervention

Isabelle Johansson et al.